Detalles de la búsqueda
1.
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group.
J Viral Hepat
; 29(7): 551-558, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35548866
2.
Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
J Med Virol
; 93(11): 6247-6256, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170517
3.
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Hepatol Res
; 49(3): 264-270, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171740
4.
Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Hepatol Res
; 49(10): 1114-1120, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077527
5.
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.
Hepatol Res
; 48(9): 746-756, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29480939
6.
Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study.
JGH Open
; 8(4): e13068, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38681824
7.
[A case of inoperable advanced bile duct cancer treated effectively with combined chemotherapy of gemcitabine and S-1].
Gan To Kagaku Ryoho
; 40(2): 259-62, 2013 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-23411968
8.
Real-world long-term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection.
JGH Open
; 6(5): 344-352, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35601120
9.
Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study.
Cancers (Basel)
; 14(12)2022 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740647
10.
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study.
Cancers (Basel)
; 13(11)2021 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34073396
11.
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients.
Liver Cancer
; 9(1): 50-62, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071909
12.
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
J Gastroenterol
; 53(10): 1142-1150, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29626296
13.
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
PLoS One
; 13(4): e0194704, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659591
14.
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure.
PLoS One
; 11(10): e0165339, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27776192
15.
[A case of gastrointestinal stromal tumor of the duodenum with increased color flow signals].
Nihon Shokakibyo Gakkai Zasshi
; 99(7): 820-7, 2002 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-12170712
Resultados
1 -
15
de 15
1
Próxima >
>>